In vivo markers of oxidative stress and therapeutic interventions.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Cardiology

• Publication date

  2008-05-22

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.amjcard.2008.02.006PMID 18474272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation in Atherosclerosis

  2012cited by this paper
• Lipoprotein-Associated Phospholipase A2

  2012cited by this paper
• The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.

  2008cited by this paper
• Measurement of plasma oxidized low-density lipoprotein and its clinical implications.

  2007cited by this paper
• Oxidized Phospholipids, Lipoprotein(a), Lipoprotein-Associated Phospholipase A2 Activity, and 10-Year Cardiovascular Outcomes: Prospective Results From the Bruneck Study

  2007cited by this paper
• Increased Plasma Oxidized Phospholipid:Apolipoprotein B-100 Ratio With Concomitant Depletion of Oxidized Phospholipids From Atherosclerotic Lesions After Dietary Lipid-Lowering: A Potential Biomarker of Early Atherosclerosis Regression

  2007cited by this paper
• New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A2 in Atherosclerosis and Cardiovascular Disease

  2007cited by this paper
• Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.

  2006cited by this paper
• Lipoprotein-associated phospholipase A2.

  2006cited by this paper
• Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease

  2006cited by this paper
• Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia.

  2006cited by this paper
• Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein.

  2006cited by this paper
• Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?

  2006cited by this paper
• Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.

  2006cited by this paper
• C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.

  2006cited by this paper
• Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients.

  2006cited by this paper
• Lipoprotein-Associated Phospholipase A2 and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction) Trial

  2006cited by this paper
• The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome.

  2006cited by this paper
• Measures of oxidative stress.

  2006cited by this paper
• Oxidized‐LDL levels are changed during short‐term serum glucose variations and lowered with statin treatment in early Type 2 diabetes: a study of endothelial function and microalbuminuria

  2005cited by this paper
• Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects.

  2005cited by this paper
• Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.

  2005cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• Formation of dysfunctional high-density lipoprotein by myeloperoxidase.

  2005cited by this paper
• Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up.

  2005cited by this paper
• Statins downregulate myeloperoxidase gene expression in macrophages.

  2005cited by this paper
• Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised‐controlled trial

  2005cited by this paper
• Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans

  2004cited by this paper
• High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial

  2004cited by this paper
• Changes in Dietary Fat Intake Alter Plasma Levels of Oxidized Low-Density Lipoprotein and Lipoprotein(a)

  2004cited by this paper
• Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans

  2004cited by this paper
• Effects of statins on circulating oxidized low-density lipoprotein in patients with hypercholesterolemia.

  2004cited by this paper
• Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL

  2004cited by this paper
• Percutaneous Coronary Intervention Results in Acute Increases in Oxidized Phospholipids and Lipoprotein(a): Short-Term and Long-Term Immunologic Responses to Oxidized Low-Density Lipoprotein

  2004cited by this paper
• Lipoprotein-Associated Phospholipase A2 Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population: Results From the 14-Year Follow-Up of a Large Cohort From Southern Germany

  2004cited by this paper
• F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases.

  2004cited by this paper
• Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study

  2004cited by this paper
• Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes

  2003cited by this paper
• Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways

  2003cited by this paper
• Effects of atorvastatin and pravastatin on malondialdehyde-modified LDL in hypercholesterolemic patients.

  2003cited by this paper
• Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments.

  2003cited by this paper
• Prognostic value of myeloperoxidase in patients with chest pain.

  2003cited by this paper
• Lysine-Phosphatidylcholine Adducts in Kringle V Impart Unique Immunological and Potential Pro-inflammatory Properties to Human Apolipoprotein(a)*

  2003cited by this paper
• Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.

  2003cited by this paper
• Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis.

  2003cited by this paper
• Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy.

  2003cited by this paper
• Inflammation in atherosclerosis

  2002cited by this paper
• Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress.

  2002cited by this paper
• Low-Density Lipoprotein Level Reduction by the 3-Hydroxy-3-Methylglutaryl Coenzyme-A Inhibitor Simvastatin Is Accompanied by a Related Reduction of F2-Isoprostane Formation in Hypercholesterolemic Subjects: No Further Effect of Vitamin E

  2002cited by this paper
• Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia.

  2002cited by this paper
• Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime

  2002cited by this paper
• Correlation of Antiphospholipid Antibody Recognition with the Structure of Synthetic Oxidized Phospholipids

  2002cited by this paper
• Atherosclerosis The Road Ahead

  2001cited by this paper
• Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

  2001cited by this paper
• Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target.

  2001cited by this paper
• Association between myeloperoxidase levels and risk of coronary artery disease.

  2001cited by this paper
• A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.

  2001cited by this paper
• Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.

  2000cited by this paper
• Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease.

  2000cited by this paper
• Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.

  1999cited by this paper
• The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis.

  1999cited by this paper
• Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice

  1998cited by this paper
• Localization of distinct F2-isoprostanes in human atherosclerotic lesions.

  1997cited by this paper
• Correlation between Oxidized Low Density Lipoproteins and von Willebrand Factor in Chronic Renal Failure

  1996cited by this paper
• PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.

  1996cited by this paper
• Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody.

  1996cited by this paper
• Enhanced Association of Platelet-activating Factor Acetylhydrolase with Lipoprotein (a) in Comparison with Low Density Lipoprotein (*)

  1995cited by this paper
• Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.

  1995cited by this paper
• A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides.

  1994cited by this paper
• Atherosclerosis and Cardiovascular Disease

  1990cited by this paper

• Changes in Oxidative Stress, Inflammatory Markers, and Lipid Profile After a 6-Week High-Antioxidant-Capacity Dietary Intervention in CVD Patients

  2025cites this paper
• Plasma myeloperoxidase interactions with cadmium, lead, arsenic, and selenium and their impact on chronic kidney disease.

  2025cites this paper
• The Association of Single Nucleotide Polymorphism rs5883 in The CETP Gene with Oxidized-LDL Level in Coronary Atherosclerosis Patients

  2023cites this paper
• Oxidized phospholipids and lipoprotein(a): An update

  2021cites this paper
• Oxidized LDLs as Signaling Molecules

  2021cites this paper
• Metabolomics to Diagnose Oxidative Stress in Perinatal Asphyxia: Towards a Non-Invasive Approach

  2021cites this paper
• Biomarkers of Oxidative Stress in Respiratory Diseases

  2020cites this paper
• Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule

  2020cites this paper
• Physiological Benefits of Exercise Programs for Youths with Down Syndrome. A Systematic Review

  2020cites this paper
• The Role of Traditional Chinese Medicine in the Regulation of Oxidative Stress in Treating Coronary Heart Disease

  2019cites this paper
• Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients.

  2019cites this paper
• Oxidative stress markers and antioxidant activity in patients admitted to Intensive Care Unit with acute myocardial infarction

  2018cites this paper
• Dapsone protects brain microvascular integrity from high-fat diet induced LDL oxidation

  2018cites this paper
• Evaluation of physiological parameters of the plasma oxidative status in rabbits

  2017cites this paper
• Evaluation of Malondialdehyde Low-Density Lipoprotein Stratified by Low-Density Lipoprotein Cholesterol.

  2017cites this paper
• 87 – Consequences of Sleep Disruption

  2016cites this paper
• Effects of phenol-enriched olive oils on HDL and endothelial functions in cardiovascular risk individuals

  2015cites this paper
• Mass Spectrometry-Based Methods for Identifying Oxidized Proteins in Disease: Advances and Challenges

  2015cites this paper
• Antioxidants and coronary artery disease: from pathophysiology to preventive therapy

  2015cites this paper
• The significance of lipid peroxidation in cardiovascular disease

  2014cites this paper
• Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry.

  2014cites this paper
• Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial.

  2014cites this paper
• Genetic polymorphisms of myeloperoxidase and their effect on hypertension

  2013cites this paper
• Estrés oxidativo inducido por el ejercicio

  2013cites this paper
• Kit Radicaux Libres, A Biological Application for Monitoring Oxidative Stress in Pigs

  2013cites this paper
• Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis.

  2013cites this paper
• Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics

  2013cites this paper
• Pre-clinical Evaluation of Hemoglobin Based Oxygen Carriers: Animal Models and Biomarkers

  2013cites this paper
• Consequences of oxidative stress in age-related macular degeneration.

  2012cites this paper
• Estudo da atividade e polimorfismos da Paraoxonase-1 em indivíduos infectados pelo vírus da imunodeficiência humana tipo-1 (HIV-1) tratados com inibidores de protease

  2012cites this paper
• Development of a fast and simple LC-MS/MS method for measuring the F2-isoprostanes in newborns

  2012cites this paper
• The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.

  2012cites this paper
• The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin.

  2012cites this paper
• Biomarkers of Oxidative Stress in Plasma and Urine

  2012cites this paper
• N-acetylcysteine prevents pulmonary edema and acute kidney injury in rats with sepsis submitted to mechanical ventilation.

  2012cites this paper
• Hs-CRP may be associated with white blood cell count in metabolic syndrome patients treated with Ginkgo biloba.

  2011cites this paper
• Oxidative stress biomarkers as predictors of cardiovascular disease.

  2011cites this paper
• Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation

  2011cites this paper
• Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris.

  2011cites this paper
• [Intimomedial thickness of the vertebral arteries complex: a new useful parameter for the assessment of atheroclerotic process?].

  2011cites this paper
• Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease.

  2011cites this paper
• Animal Models and Oxidative Biomarkers to Evaluate Preclinical Safety of Extracellular Hemoglobins

  2011cites this paper
• Temporal Dissociation between Myeloperoxidase (MPO)-Modified LDL and MPO Elevations during Chronic Sleep Restriction and Recovery in Healthy Young Men

  2011cites this paper
• Relation of oxidative biomarkers, vascular dysfunction, and progression of coronary artery calcium.

  2010cites this paper
• Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia

  2010cites this paper
• Little change in markers of protein breakdown and oxidative stress in humans in immobilization-induced skeletal muscle atrophy.

  2010cites this paper
• Isoprostanes as markers of oxidative stress-induced cell damage in porcine islet cell isolation.

  2010cites this paper
• Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options

  2010cites this paper
• Mechanisms of LDL oxidation.

  2010cites this paper
• Assessment of antioxidants in foods and biological samples: a short critique

  2010cites this paper
• Prevention of oxidative stress in porcine islet isolation

  2010cites this paper
• Generation and Biological Activities of Oxidized Phospholipids

  2010cites this paper
• Angioscopic Detection of Vulnerable Coronary Plaques

  2010cites this paper
• Lipoprotein(a) and the risk of vascular disease

  2010cites this paper
• Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events.

  2010cites this paper
• COMPREHENSIVE INVITED REVIEW Generation and Biological Activities of Oxidized Phospholipids

  2010cites this paper
• Вредности оксидисаног LDL-холестерола и C-реактивног протеина у односу на дебљину зида каротидне артерије код особа с факторима ризика за атеросклерозу

  2009cites this paper
• Physiopathologie de l’athérosclérose et marqueurs précoces

  2009cites this paper
• Estrés oxidativo inducido por el ejercicio

  2009cites this paper
• Atherogenic modifications of LDL particles in diabetic patients

  2009cites this paper
• An innocent bystander in the coronary tree.

  2009cites this paper
• Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Choleste

  2009cites this paper
• More knocks to the oxidation hypothesis for vascular disease?

  2009cites this paper
• The role of NADPH oxidase in blood -brain barrier dysfunction following stroke in aged rats

  2009cites this paper
• [Oxidized LDL and C-reactive protein level in relation to carotid intima-media thickness in population with risk factors for atherosclerosis].

  2009cites this paper
• A cross-sectional study of intima-media thickness, ethnicity, metabolic syndrome, and cardiovascular risk in 2268 study participants.

  2009cites this paper
• Critical methods in Free Radical Biology & Medicine.

  2009cites this paper
• Paraoxonases role in the prevention of cardiovascular diseases

  2009cites this paper
• NOX2 inhibition with apocynin worsens stroke outcome in aged rats.

  2009cites this paper
• Evaluation of whole antioxidant defenses of human mononuclear cells by a new in vitro biological test: lack of correlation between erythrocyte and mononuclear cell resistance to oxidative stress.

  2009cites this paper
• High-salt diet combined with elevated angiotensin II accelerates atherosclerosis in apolipoprotein E-deficient mice

  2009cites this paper
• Environmental tobacco smoke and cardiometabolic risk in young children: results from a survey in south-west Germany.

  2009cites this paper
• Is myeloperoxidase a useful marker to predict the risk of cardiovascular events?

  2009cites this paper
• Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method.

  2009cites this paper
• Emerging environmental, molecular, and genetic risk factors in stable coronary artery disease

  2009cites this paper
• Evaluation of physiological parameters of plasma oxidative status in rabbits

  year unknowncites this paper